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Ehlers–Danlos syndrome (EDS) type VIIC, or dermatosparactic type, is a recessively inherited connective tissue
disorder characterized, among other symptoms, by an extreme skin fragility resulting from mutations inactivating
ADAMTS-2, an enzyme excising the aminopropeptide of procollagens type I, II, and III. All previously described
mutations create premature stop codons leading to a marked reduction in the level of mRNA. In this study,
we analyzed the ADAMTS2 cDNA sequences from ﬁve patients displaying clinical and/or biochemical features
consistent with a diagnosis of either typical or potentially mild form of EDS type VIIC. Three different
alterations were detected in the two patients with typical EDS type VIIC. The ﬁrst patient was homozygous for
a genomic deletion causing an in-frame skipping of exons 3–5 in the transcript. In the second patient, the
allele inherited from the mother lacks exon 3, generating a premature stop codon, whereas the paternal allele
has a genomic deletion resulting in an in-frame skipping of exons 14–16 at the mRNA level. Although the exons
3–5 or 14–16 encode protein domains that have not been previously recognized as crucial for ADAMTS-2
activity, the aminoprocollagen processing was strongly impaired in vitro and in vivo, providing evidence for the
requirement of these domains for proper enzyme function. The three other patients with a phenotype with some
resemblance to EDS type VIIC only had silent and functionally neutral variations also frequently found in a
normal population.
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Ehlers–Danlos syndrome (EDS) is a heterogeneous group of
inherited connective tissue disorders characterized by al-
tered mechanical properties of skin, joints, blood vessels,
and ligaments (Beighton et al, 1998; Steinmann et al, 2002).
EDS type VIIC (MIM 225410) (Nusgens et al, 1992; Smith
et al, 1992; Fujimoto et al, 1997) and the related animal
disease (dermatosparaxis) (Hanset and Ansay, 1967) are
recessively inherited connective tissue disorders. They re-
sult from a defect in the processing of type I procollagen to
collagen, with accumulation in most tissues of molecules
that retain the amino-terminal propeptide (Lenaers et al,
1971). These precursor molecules self-assemble into ab-
normal ribbon-like fibrils that fail to provide normal tensile
strength to tissues (Pie´rard and Lapie`re, 1976; Nusgens
et al, 1992). The defect in the processing of type I procol-
lagen reflects the absence of functional ADAMTS-2, an en-
zyme removing the aminopropeptide of type I, type II, and
type III procollagen (Lapie`re et al, 1971; Colige et al, 1995,
1997; Wang et al, 2003). ADAMTS-2 is a metalloproteinase
of the ADAMTS family containing, among other features, a
Zn2þ -binding catalytic site required for its procollagen
processing activity, and four thrombospondin type I repeats
(TSPI) most probably crucial for the recognition of the
substrate and the 3D-structure of the protein. Three differ-
ent mutations have been reported so far in the ADAMTS2
gene (Colige et al, 1999). They generate stop codons re-
sulting in a marked decrease of the level of mRNA.
In this study, the cDNA and the genomic DNA of two
patients displaying a typical EDS type VIIC phenotype (P7
and P8) were analyzed. We showed that two of the three
mutations in these new patients permit stable mRNA to ac-
cumulate and predict that they lead to synthesis of proteins
that lack activity or are degraded. In addition, in order to
identify potential mutations affecting the enzyme activity
less severely, analyses were performed also on cDNA fromAbbreviation: EDS, Ehlers–Danlos Syndrome
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patients presenting only some of the clinical signs of the
disease (cases 1–3).
Results
Mutation detection The ADAMTS2 cDNA from the five
patients and from control individuals were PCR-amplified
using five primer pairs and separated on agarose gel. Nor-
mal amplification products were obtained for all samples
except for product 1 (undetectable) and 2 (  450 bp small-
er than expected) from P7 and product 4 (  390 bp smaller
than expected) from P8 (Fig 1A). Sequencing of the purified
products showed that these alterations resulted from the
absence, at the cDNA level, of bases 535–975 for P7 and
bases 2086–2457 for P8, þ1 being the A of the ATG start
codon (Fig 1B). Determination of the exon/intron structure of
the ADAMTS2 gene was required for the identification of the
molecular defect leading to these deletions. Since the hu-
man genome sequence containing the ADAMTS2 gene was
not yet available, three overlapping clones covering the en-
tire gene were isolated from a human genomic DNA BAC
library. By FISH, PCR, and sequencing, it was demonstrated
that the gene, located on chromosome 5 (5q35), contains
22 exons (Fig 1B) separated by 21 introns of various sizes
(from 425 bp to 450 kbp). The sequence absent from the
cDNA of P7 corresponded exactly to exons 3–5 (Fig 1B).
PCR amplifications of exon/intron junctions (  200 bp frag-
ments) in this region of the gene (E2-I2, I2-E3, E5-I5, and I5-
E6) was performed (Fig 2A). For P7, PCR products were
obtained using primer pairs designed to amplify the E2/I2
and I5/E6 borders but not with primers specific for the I2/E3
or E5/I6 borders, indicating that the in-frame skipping of
exons 3–4–5 is caused by a deletion starting in the  70
kbp intron 2 and ending in the  25 kbp intron 5. The exact
border of the deletion was not determined. Analysis of the
cDNA of his parents was also performed, using a forward
primer in exon 2 and a reverse primer in exon 7. PCR prod-
uct amplified from the WT sequence was observed for the
control and the parents but not for P7, confirming his ho-
mozygous status for the deletion (Fig 2B). The DNA product
corresponding to the E3 to E5-deleted allele was obtained
from P7 but was also present in both parents, although at a
very low level as illustrated by comparison of the amount of
the two PCR products amplified after 28 and 31 cycles. In
order to confirm the presence of the deleted allele in par-
ents, a deletion-specific PCR was set up (Fig 2C). It con-
sisted in the use of a forward primer in exon 2 and a reverse
primer designed to be specific for the exon 2–exon 6 fusion
sequence, a sequence found only in the deleted cDNA. PCR
product was obtained for P7 and his parents but not for the
control, confirming the data shown in panel B.
For P8, sequencing of product 4 (Fig 1A) indicated that
the sequence absent at the cDNA level corresponds to ex-
ons 14–16 (Fig 1B). In order to elucidate the cause of the
skipping of these exons, the cDNA and the genomic DNA of
the patient, his parents and a normal control were further
analyzed. PCR amplification of genomic DNA using primer
pairs located on exon 13 and 17 yielded only one band of
the expected size (7.9 kbp) for the mother and the control
and two bands for P8 and his father, suggesting the pres-
ence of a 5.9 kbp deletion (Fig 3A). Sequencing of the 2 kbp
product revealed that the entire region from base 1422 of
the 3008-bp intron 13 to base 1335 of the 1813-bp intron 16
was skipped and that a TCC triplet insertion occurred at the
deletion junction. PCR amplification of cDNA using primers
located on exon 13 and exon 18 showed only the WT
product for the control and the mother of P8 whereas, for
the father, WT and deleted product were present and dis-
played similar intensities (Fig 3B). For P8, the WT product
was also amplified but at a very low level requiring 31 cycles
of amplification for visualization. These results suggested
that P8 inherited the exons 14–16-deleted allele from his
father and the other allele from his mother. This maternal
allele should contain a premature stop codon leading to an
efficient process of nonsense-mediated decay explaining
why the message produced from this allele can barely be
seen here (Fig 3B) and was not initially detected by RT-PCR
(Fig 1A, product 4, P8). In order to identify the mutation
affecting the maternal allele of P8, two primer pairs were
designed, one with the forward primer in exon 1 and the
reverse primer in exon 16 and the second one with the for-
ward primer in exon 15 and the reverse primer in the 30-
untranslated sequence. Since exons 15 and 16 are absent
from the paternal allele (Fig 1B), this strategy allowed to
specifically amplify the maternal allele. Sequence of this
maternal-amplified DNA revealed that the sequence corre-
sponding to exon 3 is absent. This leads to a frame shift,
generating a new amino acid sequence from the beginning
of exon 4 (GPPWTAWTASAAPWAS) followed by a prema-
ture stop codon upstream of the sequence that normally
codes for the catalytic site of the enzyme. As a confirma-
tion, RT-PCR amplification of the ADAMTS2 cDNA using a
forward primer in exon 2 and the reverse primer in exon 4
shows two bands for P8 and his mother, the smallest one
being the product lacking exon 3 (Fig 3C). The strong dif-
ference in the level of the two products clearly illustrates an
active process of nonsense-mediated decay affecting the
message containing the premature stop codon. Presence of
the allele lacking exon 3 was also illustrated by using an-
other primer pair (Fig 2B, P8).
Analysis of the cDNA from cases 1–3 revealed two dif-
ferences compared to the published sequence: a G to A
transition (733G ! A) changing a codon for valine into a
codon for isoleucine (Val225Ile) and a C to T transition
(3529C ! T) changing a codon for proline into a codon for
serine (Pro1177Ser) (Fig 1B). Case 1 was heterozygous at
these two positions (Val/Ile and Pro/Ser) whereas case 2
(Ile/Ile and Ser/Ser), P7, P8, and case 3 (Val/Val and Pro/Pro)
were homozygous. A similar study was performed in a nor-
mal population (50 unrelated individuals). The calculated
allele frequency was 70/30 for G/A at position 733 and 62/
38 for C/T at position 3529.
Ultrastructure of dermal collagen ﬁbrils and procollagen
processing In normal skin, collagen fibrils appear cylindri-
cal in cross section and elongated with a typical banded
pattern in longitudinal section (Fig 4A and B). In the skin of
P7 and P8, fibrils were hieroglyphic in cross section and
frayed and disorganized in longitudinal section (Fig 4D–F).
This pattern was identical to the pattern observed in other
EDS VIIC patients, in the dermatosparactic calf and in
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Figure 1
Mutation analysis. (A) RNA from the patients and from a normal control were reverse transcribed and amplified using five different primer pairs
generating overlapping products covering the entire ADAMTS2 cDNA. Localization of the five products is given relative to the exon structure of the
cDNA. Only the products 1, 2, and 4 from P7, P8 and the normal control are shown here. For P7, PCR product 1 was absent and the size of PCR
product 2 was smaller than expected. For P8, product 4 was of smaller size as compared to other samples. These data suggest the presence of a
deletion in the region of exons 3–5 for P7 and of exons 14–16 for P8. (B) Schematic representation of the exon structure (exons 1–22) of the coding
sequence of the ADAMTS2 cDNA. The localization of the sequence polymorphisms and mutations in P7 and P8 are reported, with A of the ATG start
codon being referred to as þ1. Mutations causing the disease in patient 1 (P1), in patients 2–6 (P2 ! 6) and in the dermatosparactic calves (D calf)
have been reported earlier (Colige et al, 1999). (C) The upper part of the panel represents the functional domains of a normal ADAMTS-2 enzyme.
The double arrows indicate the part of the enzyme which is synthesized in the patients and in the dermatosparactic calf, on the basis of the presence
of either premature stop codons or deletion at the mRNA level, but without considering the effect of nonsense-mediated decay process. For P7 and
P8, the dotted line represents the missing protein sequence resulting from the exon skipping. D calf and P1–P7 are homozygous for their respective
mutation, whereas P8 is a compound heterozygous explaining why the product from the two alleles is represented.
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ADAMTS-2 deficient mice (Fig 4C) and clearly different from
the pattern observed in EDS VIIA and B (Byers et al, 1997).
Collagen synthesis and processing were also evaluated
in the culture of fibroblasts grown from skin biopsies (Fig 5).
Analysis of the collagen secreted in the culture medium of
fibroblasts of P7 and P8 revealed an almost complete ab-
sence of fully processed type I chains (a1 and a2) and some
accumulation of type I aminoprocollagen (pNa1 and pNa2),
evidencing a strong reduction of aminoprocollagen pep-
tidase activity. As another consequence of this altered
enzymatic activity, type I carboxyprocollagens (pCa1 and
pCa2) are not found since, in absence of aminoprocollagen
processing, the only procollagen polypeptides retaining the
C-propeptide are a1 and a2 procollagens (pro a1 and pro
a2). For cases 1 and 2, similar but milder alterations of the
procollagen profile were observed, suggesting a mild re-
duction of the aminoprocollagen I peptidase activity, where-
as the processing determined for case 3 was similar to that
observed with control cell strains.
Discussion
Ehlers–Danlos type VIIC is a rare inherited connective tissue
disorder caused by mutations affecting the gene for AD-
AMTS-2, the enzyme responsible for the excision of the
aminopropeptide of type I procollagen. To date, three dif-
ferent mutations generating a premature stop codon have
been reported: one in the calf, the second in one Belgian
patient and the third in five unrelated patients of various
origins (Colige et al, 1999).
In this study, the presence of a mutation affecting the
ADAMTS2 gene was searched in five additional patients.
Two of them, P7 and P8, had highly fragile skin and most
typical hallmarks of EDS type VIIC. The three other patients,
designated as cases 1–3, displayed only some of the fea-
tures typical of the disease. For P7 and P8, the EDS type
VIIC diagnosis was confirmed by in vitro biochemical stud-
ies, showing the near absence of fully processed a chains
and accumulation of a1 and a2 aminoprocollagen I, and by
evaluation of the shape of type I collagen fibril in vivo,
showing the typical hieroglyphic pattern characteristic of
EDS type VIIC. Besides the different clinical features, these
Figure 2
Genomic DNA analysis and homo/heterozygosity in the family of
P7. (A) PCR amplification of genomic DNA from P7 and a control (C)
was performed using primers specific for various exon/intron borders in
exons 2–6 part of the ADAMTS2 gene. For P7, PCR products were
obtained using primer pairs designed to amplify the E2/I2 and I5/E6
borders but not with primers specific for the I2/E3 or E5/I6 borders,
indicating that the in-frame skipping of exons 3–4–5 is caused by a
deletion starting in intron 2 and ending in intron 5. (B) PCR amplifica-
tions of cDNA from a control (C), P7 and his parents (father: FP7;
mother: MP7), and P8 were performed, using 28 (28#) and 31 (31#)
cycles, with a forward primer in exon 2 and a reverse primer in exon 7.
Product of normal size (WT) was amplified for the control and the par-
ents, whereas the product lacking exons 3–5 (D, E3–E5) was obtained
for P7 and his parents. (C) Allele-specific PCR was performed using a
forward primer in exon 2 and a reverse primer designed to be specific
of the exon 2/exon 6 fusion sequence (30-CCGAC/AGGTACTCGGAG-
TAGCTC-50). PCR product was obtained only for P7 and his parents,
confirming the homo/heterozygosity status suggested by data shown in
panel B.
Figure3
Genomic DNA analysis and homo/heterozygosity in the family of
P8. (A) PCR amplification of genomic DNA from P8, his parents (father:
FP8; mother: MP8), and a control (C) was performed using a primer pair
allowing the amplification of the part of the ADAMTS2 gene extending
from exons 13–17. Only the product of expected size (WT: 7.9 kbp) was
amplified for the mother and the control whereas two bands (WT: 7.9
kbp and D: 2 kbp) were observed for P8 and his father, suggesting the
existence of a 5.9 kbp deletion. (B) PCR amplifications of cDNA from a
control (C), P8, and his parents (father: FP8; mother: MP8) were per-
formed, using 28 (28#) and 31 (31#) cycles, with primers located on
exons 13 and 18. The full size product (WT) only was amplified from
cDNA of the control and the mother of P8. For the father, the WT and
deleted product (D, E14–E16) were both detected. In contrast, the WT
product amplified from P8 was almost undetectable (arrow). (C) PCR
amplification of cDNA from a control (C), P8, and his parents using
primers located on exons 2 and 4. The full size product (WT) was
observed for all samples whereas the product lacking exon 3 (D, E3)
was seen only in samples from P8 and his mother.
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observations excluded the diagnosis of the related EDS
type VIIA or B, that would have caused an accumulation of
either a1 or a2 aminoprocollagen I chain and resulted in a
less dramatic alteration of the pattern of collagen fibrils
(Byers et al, 1997). P7 is homozygous for a genomic de-
letion inherited from his heterozygous parents. This dele-
tion, starting in intron 2 and ending in intron 5, results in the
absence of exons 3–5 from the ADAMTS2 mRNA and is
probably responsible for the very low level of the altered
mRNA. If the small amount of mRNA lacking exons 3–5 can
be translated, it would result in the production of low levels
of an enzyme still containing the catalytic site and the entire
downstream sequences but lacking the end of the pro-do-
main and the beginning of the metalloprotease domain (Fig
1C). This region of the enzyme does not contain Cys res-
idues which are often important for the 3D-folding of pro-
teins but does contain a cleavage site by furin which is
crucial for the activation processes of many enzymes in-
cluding ADAMTS (Rodriguez-Manzaneque, 2000). There-
fore, the defect in aminoprocollagen-processing activity in
this patient may result from the low level of ADAMTS-2 and/
or the absence of activation process of ADAMTS-2 at the
furin cleavage site.
P8 is the first example of an EDS type VIIC caused by
compound heterozygosity. In the allele from the mother,
deletion at the mRNA level of exon 3 resulted in a frame
shift, generating a premature stop codon upstream of the
catalytic site and a very efficient process of nonsense-me-
diated decay. Identification of the molecular defect causing
the skipping of exon 3 was not successful, because the size
of introns 2 and 3 (about 70 kbp each) did not allow the PCR
amplification of this entire region of the gene and because
the compound heterozygous status prevented identification
of a deletion by using exon 3-specific primers. In the allele
Figure 4
Structure of collagen fibrils. Collagen
fibrils from skin of human (A, D, E, F) and
mouse (B, C) were studied by transmis-
sion electron microscopy. In normal skin
(A, B), collagen fibrils appear cylindrical in
cross section and elongated with a typical
banded pattern in longitudinal section. In
the animal model for the disease (C, AD-
AMTS2 null mouse), and in EDS type VIIC
patients (D: P7; E, and F: P8), fibrils are
hieroglyphic in cross section and disor-
ganized in longitudinal section. The level
of observed hieroglyphic pattern is influ-
enced by the angle of the section and can
vary slightly between different regions
within a single skin biopsy (C–F). Scale
bar¼0.3 mm.
Figure 5
Electrophoretic pattern of collagen polypeptides. Fluorograms of 14C-proline-labeled collagen polypeptides collected from the culture medium
of skin fibroblasts of two normal control individuals (Cont A and B), of P7 and his parents (MP7, FP7), P8 and his parents (MP8 and FP8), and Cases
1–3. The right and left panels correspond to two different labeling experiments. The various type I collagen polypeptides are indicated. The two
bands, above and under the proa1 band, are proa1 III and pNa1 III. Although some variability in the processing of type I procollagen by normal
human fibroblasts can exist (compare Cont A and B), the illustrated control patterns are representative examples. Note in P7 and P8 the lack of
processing of proa1 and proa2 into the C-terminal extended polypeptides (pCa1 and pCa2); the near absence of fully processed a1 and a2 chains
and some accumulation of pNa1 and pNa2, all of these features being characteristic of decreased aminoprocollagen peptidase activity. For cases 1
and 2, similar but milder alterations of the procollagen profile were observed, whereas the processing determined for case 3 was similar to that
observed in control cell strains.
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inherited from his father, a genomic deletion extending from
intron 13 to 16 results in an in-frame deletion of exons 14–16
at the mRNA level. Although this region of the gene does not
encode domains known to be important for the ADAMTS-2
function, this deletion clearly affected the enzyme activity
in vivo as demonstrated by the alteration of collagen fibrils.
The specific role of this part of ADAMTS-2 is not yet elu-
cidated but we speculate that this region might be involved
in the correct folding of the protein, in the adequate spacing
between the thrombospondin type I repeats or in the rec-
ognition of the substrate. Similar requirement for enzymatic
activity of the various C-terminal domains, including the
Cys-rich and the spacer regions, have been reported for
other ADAMTS enzymes such as ADAMTS-1, -4, -9 and -13
(Kuno et al, 1998; Tortorella et al, 2000; Somerville et al,
2003; Zheng et al, 2003). The delayed onset of a typical
phenotype for P8 highlights the fact that a correct diagnosis
of EDS type VIIC cannot always be made at birth, but
sometimes requires follow-up of the patient during the first
years of life. We cannot rule out the possibility that this
slightly different phenotype reflects the presence of residual
activity, possibly developmentally regulated, of ADAMTS-2
lacking the region encoded by exons 14–16. Since another
ADAMTS, ADAMTS-13, can process von Willebrand factor
(George et al, 2002), another intriguing feature for this pa-
tient was the presence of a mild form of von Willebrand
disease type I. Since no overlap has been described so far
between ADAMTS-2 and ADAMTS-13 in terms of tissue
localization and synthesis, mechanism of activation and
substrate specificity, the occurrence of the two diseases in
one patient may be fortuitous. Reappraisal of von Wille-
brand factor levels in the other EDS type VIIC patients
would help to elucidate this point.
For cases 1–3, clinical diagnosis was not suggestive of a
typical EDS type VIIC because these patients display only
some of the features of the disease. The pattern of collagen
polypeptides secreted by the fibroblasts in culture was
characterized and the relative abundance of aminoprocol-
lagen and fully processed a chains was determined as a
mean to evaluate the aminoprocollagen peptidase activity.
For case 3, the collagen pattern was normal and no mu-
tation was detected in the ADAMTS2 cDNA. For fibroblasts
from cases 1 and 2, a significant reduction of the procol-
lagen processing was observed, that could have been
caused by mutations only mildly affecting ADAMTS-2 ac-
tivity. Sequencing of the cDNA revealed two differences as
compared to the published sequence. Screening of 50
cDNAs, however, from normal individuals showed that
these modifications are relatively common and should be
considered as polymorphisms that do not affect the AD-
AMTS-2 function. ADAMTS-3 and -14 are two other en-
zymes displaying aminoprocollagen peptidase activity
(Fernandes et al, 2001; Colige et al, 2002). On this basis,
mutations in these genes could be the cause of the clinical
phenotype of cases 1 and 2. The level of expression of
ADAMTS-3 in skin and tendon is very low, strongly sug-
gesting that it is not significantly involved in the aminopro-
collagen I processing in vivo in these tissues. No further
investigation about ADAMTS-3 was performed. Because of
its relatively high level of expression, the cDNA of ADAMTS-
14 was sequenced but no mutation was identified (unpub-
lished data). Data about cases 1 and 2 suggest that the
reduced aminoprocollagen peptidase activity measured in
vitro may be due to a mutation in another protein that would
be required for optimal ADAMTS-2 function. Such a poten-
tial co-factor has not been identified yet. Observations re-
porting that native ADAMTS-2 can be isolated as a complex
with other proteins (Hojima et al, 1994), however, would
support this hypothesis.
In this study, we describe three novel mutations affecting
the ADAMTS2 gene and causing EDS type VIIC in two pa-
tients. Skipping of exons 3–5 from the mRNA of patient P7
resulted in a typical EDS type VIIC phenotype that can be
diagnosed at birth, as in previously reported EDS type VIIC
patients (Colige et al, 1999). Mono-allelic in-frame skipping
of exons 14–16, in association with another allele producing
a totally inactive protein, as observed for P8, produced a
phenotype that was only clinically identified a few months
after birth. The reduced aminoprocollagen peptidase activ-
ity observed in vitro in fibroblasts of cases 1 and 2 who do
not have an identifiable mutation in the ADAMTS2 and 14
genes suggests that mutations in other genes can alter the
processing of procollagen molecules and result in a clinical
phenotype with similarities to the phenotype of EDS type
VIIC.
Materials and Methods
Cell culture Dermal fibroblasts were grown from skin biopsies and
cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supple-
mented with 10% dialyzed and decomplemented fetal calf serum
(FCS) and 50 mg per mL ascorbic acid. The 14C-proline protein
labeling, purification of labeled procollagen, and electrophoretic
procedures were as described previously (Nuytinck et al, 1996).
DNA ampliﬁcation and sequencing Total RNA and genomic DNA
were purified from fibroblasts in culture. cDNA was synthesized
using random primers (9-mers) and Superscript II reverse tran-
scriptase (Invitrogen, Merelbeke, Belgium). Overlapping RT-PCR
products were amplified using Taq DNA polymerase (Takara, Bio-
Whittaker Europe, Verviers, Belgium) and five different pairs of
primers (product 1, 518 bp: 50-CGCTTGGTGTCCCACGTGGTGT-30
and 50-CGGCTGAGGCTGTCCAGGCTGT-30; product 2, 1034 bp:
50-TTTGGCCGAGACCTGCACCTGC-30 and 50-AGGTAGCGGCT-
CAGCTCCTGCT-30; product 3, 1110 bp: 50-GCATGCAAGGC-
Figure 6
Frontal view of P7 and P8. (A) P7 at the age of 3 y and (B) P8 at the
age of 4 y.
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TATGCTCCTGTCA-30 and 50-GGATCTCAAACATCTTGATGTAACC-
A-30; product 4, 1149 bp: 50-CTACAAGGACGCCTTCAGCCTCT-30
and 50-TGGCAGTGGCCCTTTGACGAGAT-30; product 5, 1124 bp:
50-ACAACACCACCCGCTCCGTGCA-30 and 50-CTGCTTAGCAAC-
TTGGGGCCTATT-30). Amplifications were performed using a 35
cycles program (941C for 30 s, 661C for 30 s, and 721C for 90 sec)
in an automated thermal cycler (GeneAmp PCR system 9600, Ap-
plera Belgium, Lennik, Belgium). After electrophoresis on agarose
gel, the size of the products was evaluated and the DNA was pu-
rified from excised agarose plug. The purified DNA products were
sequenced as previously described (Colige et al, 1999). For am-
plification of genomic DNA, pairs of primers were designed, al-
lowing the amplification of all the exon/intron junctions of the
22-exon gene. Sequence of the primers and PCR conditions used
for data shown in Figs 2 and 3 are available upon request
(acolige@ulg.ac.be).
Electron microscopy Mouse and human skin biopsies were fixed
for 60 min at room temperature in 2.5% glutaraldehyde in 0.1
So¨rensen’s buffer (pH 7.4), post-fixed for 30 min in 0.1% osmium
tetroxide in So¨rensen’s buffer, dehydrated in a series of ethanol
concentrations and embedded in epoxy resin (Epon 812, Fluka).
Ultrathin sections were stained with uranyl acetate and lead citrate
before being examined using a Jeol electron microscope CX100 II
at 60 kV or a Philips EM 400 at 80 kV. For P8, the skin biopsy was
initially processed for normal histology, then deparaffinized by
xylol, refixed in glutaraldehyde in 0.1 M So¨rensen’s buffer for at
least one day and then treated as described above.
Clinical descriptions All clinical investigations have been con-
ducted according to the local Ethics Committee recommendations
and the Declaration of Helsinki principles. Five patients were in-
cluded in this study. Written informed consent was obtained from
the parents of all patients and from the control individuals. Two of
them, referred as P7 and P8, had typical hallmarks of EDS type
VIIC (Beighton et al, 1998). The others, referred as cases 1–3, had
only some of the EDS type VIIC symptoms, potentially indicative of
a mild defect of the ADAMTS-2 function.
Patient 7 (Figure 6A) has a healthy sister and his parents, of Dutch
Caucasian origin, are healthy and not reported to be related. His
mother had four spontaneous abortions. Chromosome analysis
was normal in both parents. He was born, at 38þ 4/7 weeks of
gestation, by caesarian section because of his large size (3900 g).
During delivery, the short umbilical cord (18 cm) ruptured. At birth,
he had generalized edema, which gave the face a coarse appear-
ance with swollen eyelids which could not be opened initially. Other
craniofacial features included short forehead with hypertrichosis,
flat supraorbital ridges, a broad nasal root, wide nares, a smooth
philtrum, a large mouth, a thin upper lip, and micrognathia. The
large size of the fontanels and the wide cranial sutures were strik-
ing. The arms and legs were short. The hands were short and
stubby with camptodactyly of the third and fourth fingers bilater-
ally. When the edema had resolved, sagging skinfolds appeared
under the jaw reminiscent of cutis laxa. The skin was very soft and
only slowly returned into position after stretching. Psychomotor
development was normal. Joint hypermobility was noted at one
year of age. He bruised easily as he became more active. He had a
fragile skin that tore easily. Wound healing and scar formation were
normal. At the current age 7 y, the skeletal growth is normal except
for short hands and feet. The main clinical features are still the
bleeding tendency, the extensive bruising, gingival hyperplasia,
mild joint hypermobility, fragile skin, and blue sclera. Dental fea-
tures such as hypodontia were observed and will be described
further elsewhere (Malfait et al, in press).
Patient 8 (Figure 6B) was born prematurely after 34 weeks of ges-
tation by cesarian section due to breech presentation and poly-
hydramnios. He was the second child of healthy, unrelated parents.
At birth, the only abnormality noted was a large anterior fontanel
(3  3 cm). Delay in psychomotor development became evident
over the ensuing months. There was increased bulging of the an-
terior fontanel, eyelid edema, umbilical hernia, and bleeding ten-
dency. During three hospital admissions between 6 and 10 months
of age, various diagnostic procedures were performed. Normal or
irrelevant findings were obtained by ophthalmologic examination,
urinary screening for organic acids, visual evoked potentials, and
electroencephalograph. The karyotype was normal. Cerebral MRI
scan showed an Arnold–Chiari malformation and turricephaly. Re-
peated coagulation analyses demonstrated a low level of von
Willebrand factor, in keeping with a mild form of von Willebrand
disease type I. Bone development was delayed. In the second year
of life, clinical observations revealed that the skin was very soft and
stretchable and that minimal mechanical trauma cause hem-
atomas, wounds, and displacement of joints. The diagnosis of EDS
type VIIC was proposed on the basis of the characteristic ultra-
structural appearance of collagen fibrils. There was no myopia,
osteopenia, or hip dysplasia. The early severe growth retardation
resolved progressively. At current age five years, his weight (14 kg)
and height (101 cm) are on the third percentile and his head cir-
cumference (51 cm) on the 25th percentile. Oro-dental features
such as irregular occlusal morphology and enamel attrition were
diagnosed (Malfait et al, in press). Recently, he suffered a ruptured
urinary bladder diverticulum with urinary ascites. Complications
occurred during the operation because of the extreme fragility of
the tissues. The main current clinical features are still the bleeding
tendency, the extensive bruising, mainly of the buccal mucosa,
gingival hyperplasia, hypermobile joints, fragile skin, and blue
sclera.
Cases 1–3 Case 1 and 2 were born prematurely at 34 and 32 wk of
gestation. They had facial dysmorphisms and a large umbilical
hernia. Skin and mucosal fragility, and a tendency to develop
hematomas were apparent from the early years of life. Wound
healing resulted in atrophic scars. They suffered from a non-trau-
matic bladder rupture at the age of 5 and 4 y, respectively. Based
upon biochemical data and clinical examinations, a diagnosis of
EDS type I, type IV, and type VI could be excluded. Normal serum
levels of copper and ceruloplasmin excluded the diagnosis of oc-
cipital horn syndrome (previously classified as EDS type IX). Case 3
had clinical similarities to cases 1 and 2 such as facial dysmorph-
isms, skin fragility, presence of atrophic scars, umbilical hernia and
a large anterior fontanel which closed with delay. In addition, ex-
treme ligamentous laxity, joint hypermobility, and abnormal palatal
formation, with an extra ridge of gingival tissue bilaterally in the
molar region, were noted.
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